BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24005963)

  • 1. Effect of honokiol on cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes.
    Jeong HU; Kong TY; Kwon SS; Hong SW; Yeon SH; Choi JH; Lee JY; Cho YY; Lee HS
    Molecules; 2013 Sep; 18(9):10681-93. PubMed ID: 24005963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kim JH; Kwon SS; Kong TY; Cheong JC; Kim HS; In MK; Lee HS
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28287454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory Effects of Aschantin on Cytochrome P450 and Uridine 5'-diphospho-glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kwon SS; Kim JH; Jeong HU; Cho YY; Oh SR; Lee HS
    Molecules; 2016 Apr; 21(5):. PubMed ID: 27128896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes.
    Kong TY; Kim JH; Kwon SS; Cheong JC; Kim HS; In MK; Lee HS
    Arch Pharm Res; 2017 Jun; 40(6):727-735. PubMed ID: 28484907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Inhibitory Effects of Synthetic Cannabinoid EAM-2201 on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kong TY; Kwon SS; Cheong JC; Kim HS; Kim JY; Lee HS
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29659506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corydaline inhibits multiple cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes.
    Ji HY; Liu KH; Lee H; Im SR; Shim HJ; Son M; Lee HS
    Molecules; 2011 Aug; 16(8):6591-602. PubMed ID: 21826053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cytochrome P450 enzymes and uridine 5'-diphospho-glucuronosyltransferases by vicagrel in human liver microsomes: A prediction of potential drug-drug interactions.
    Liu S; Wang Z; Chan E; Zhao Y; Kang J; Zhang X; Tian X
    Chem Biol Interact; 2022 Jan; 352():109775. PubMed ID: 34910929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of honokiol on the induction of drug-metabolizing enzymes in human hepatocytes.
    Cho YY; Jeong HU; Kim JH; Lee HS
    Drug Des Devel Ther; 2014; 8():2137-45. PubMed ID: 25395831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes.
    Kim JH; Kwon SS; Jeong HU; Lee HS
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of eupatilin and jaceosidin on cytochrome p450 enzyme activities in human liver microsomes.
    Ji HY; Kim SY; Kim DK; Jeong JH; Lee HS
    Molecules; 2010 Sep; 15(9):6466-75. PubMed ID: 20877236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes.
    Nakashima A; Kawashita H; Masuda N; Saxer C; Niina M; Nagae Y; Iwasaki K
    Xenobiotica; 2005 Jun; 35(6):589-602. PubMed ID: 16192110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes.
    Misaka S; Kawabe K; Onoue S; Werba JP; Giroli M; Tamaki S; Kan T; Kimura J; Watanabe H; Yamada S
    Drug Metab Pharmacokinet; 2013; 28(3):244-9. PubMed ID: 23268924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of efavirenz on UDP-glucuronosyltransferase 1A1, 1A4, 1A6, and 1A9 activities in human liver microsomes.
    Ji HY; Lee H; Lim SR; Kim JH; Lee HS
    Molecules; 2012 Jan; 17(1):851-60. PubMed ID: 22252501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.
    Wen X; Wang JS; Neuvonen PJ; Backman JT
    Eur J Clin Pharmacol; 2002 Jan; 57(11):799-804. PubMed ID: 11868802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro.
    Chang SY; Li W; Traeger SC; Wang B; Cui D; Zhang H; Wen B; Rodrigues AD
    Drug Metab Dispos; 2008 Dec; 36(12):2513-22. PubMed ID: 18787056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory Effect of Selaginellins from Selaginella tamariscina (Beauv.) Spring against Cytochrome P450 and Uridine 5'-Diphosphoglucuronosyltransferase Isoforms on Human Liver Microsomes.
    Heo JK; Nguyen PH; Kim WC; Phuc NM; Liu KH
    Molecules; 2017 Sep; 22(10):. PubMed ID: 28934153
    [No Abstract]   [Full Text] [Related]  

  • 17. The inhibitory activity of the extracts of popular medicinal herbs on CYP1A2, 2C9, 2C19 and 3A4 and the implications for herb-drug interaction.
    Fasinu PS; Bouic PJ; Rosenkranz B
    Afr J Tradit Complement Altern Med; 2014; 11(4):54-61. PubMed ID: 25392581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of probucol on cytochrome P450 activities in human liver microsomes.
    Umehara K; Shimokawa Y; Miyamoto G
    Biol Pharm Bull; 2002 Aug; 25(8):1112-4. PubMed ID: 12186421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective glucuronidation and hydroxylation of etodolac by UGT1A9 and CYP2C9 in man.
    Tougou K; Gotou H; Ohno Y; Nakamura A
    Xenobiotica; 2004 May; 34(5):449-61. PubMed ID: 15370961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibition of human cytochrome P450 by cudratricusxanthone A.
    Sim J; Choi E; Lee YM; Jeong GS; Lee S
    Food Chem Toxicol; 2015 Jul; 81():171-175. PubMed ID: 25936586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.